These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32919954)

  • 1. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
    Umar SM; Kashyap A; Kahol S; Mathur SR; Gogia A; Deo SVS; Prasad CP
    Exp Cell Res; 2020 Nov; 396(1):112282. PubMed ID: 32919954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m
    Qing Y; Dong L; Gao L; Li C; Li Y; Han L; Prince E; Tan B; Deng X; Wetzel C; Shen C; Gao M; Chen Z; Li W; Zhang B; Braas D; Ten Hoeve J; Sanchez GJ; Chen H; Chan LN; Chen CW; Ann D; Jiang L; Müschen M; Marcucci G; Plas DR; Li Z; Su R; Chen J
    Mol Cell; 2021 Mar; 81(5):922-939.e9. PubMed ID: 33434505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis.
    Kashyap A; Umar SM; Dev J R A; Mathur SR; Gogia A; Batra A; Deo SVS; Prasad CP
    J Cell Biochem; 2023 Sep; 124(9):1259-1272. PubMed ID: 37450687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet isoform of phosphofructokinase accelerates malignant features in breast cancer.
    Inaishi T; Shibata M; Ichikawa T; Kanda M; Hayashi M; Soeda I; Takeuchi D; Takano Y; Tsunoda N; Kodera Y; Kikumori T
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34751415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression.
    Fan Y; Wang J; Xu Y; Wang Y; Song T; Liang X; Jin F; Su D
    Cell Commun Signal; 2021 Feb; 19(1):18. PubMed ID: 33588886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
    Zhang YQ; Wei XL; Liang YK; Chen WL; Zhang F; Bai JW; Qiu SQ; Du CW; Huang WH; Zhang GJ
    PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.
    Xiao M; Lou C; Xiao H; Yang Y; Cai X; Li C; Jia S; Huang Y
    Br J Surg; 2018 Jan; 105(1):75-85. PubMed ID: 29116653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
    Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
    Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of a Glycolytic Signature and Its Regulation by Y-Box-Binding Protein 1 in Triple-Negative Breast Cancer.
    Lai YW; Hsu WJ; Lee WY; Chen CH; Tsai YH; Dai JZ; Yang CC; Lin CW
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India.
    Dogra A; Doval DC; Sardana M; Chedi SK; Mehta A
    Asian Pac J Cancer Prev; 2014; 15(24):10577-83. PubMed ID: 25605142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis.
    He L; Lv S; Ma X; Jiang S; Zhou F; Zhang Y; Yu R; Zhao Y
    Med Oncol; 2022 Jan; 39(4):45. PubMed ID: 35092510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress.
    Kim NH; Cha YH; Lee J; Lee SH; Yang JH; Yun JS; Cho ES; Zhang X; Nam M; Kim N; Yuk YS; Cha SY; Lee Y; Ryu JK; Park S; Cheong JH; Kang SW; Kim SY; Hwang GS; Yook JI; Kim HS
    Nat Commun; 2017 Feb; 8():14374. PubMed ID: 28176759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
    Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
    Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer.
    Yeerken D; Hong R; Wang Y; Gong Y; Liu R; Yang D; Li J; Fan J; Chen J; Zhang W; Zhan Q
    PLoS One; 2020; 15(5):e0233750. PubMed ID: 32470015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krüppel-like factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer.
    Moon JS; Kim HE; Koh E; Park SH; Jin WJ; Park BW; Park SW; Kim KS
    J Biol Chem; 2011 Jul; 286(27):23808-16. PubMed ID: 21586797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.
    Lund RR; Leth-Larsen R; Caterino TD; Terp MG; Nissen J; Lænkholm AV; Jensen ON; Ditzel HJ
    Mol Cell Proteomics; 2015 Nov; 14(11):2988-99. PubMed ID: 26351264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer.
    Huang X; Li X; Xie X; Ye F; Chen B; Song C; Tang H; Xie X
    Breast; 2016 Dec; 30():39-46. PubMed ID: 27598996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
    Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
    Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.